|
HS Code |
965326 |
| Product Name | 4-Bromo-2-Methylquinoline |
| Cas Number | 19798-73-7 |
| Molecular Formula | C10H8BrN |
| Molecular Weight | 222.08 |
| Appearance | Light yellow to brown solid |
| Melting Point | 74-78°C |
| Boiling Point | 344.9°C (estimated) |
| Purity | Typically ≥98% |
| Storage Conditions | Store at room temperature, tightly sealed |
| Solubility | Slightly soluble in water; soluble in organic solvents |
| Synonyms | 2-Methyl-4-bromoquinoline |
| Density | 1.51 g/cm³ (estimated) |
| Smiles | CC1=NC2=CC=CC=C2C=C1Br |
| Inchi | InChI=1S/C10H8BrN/c1-7-6-8-4-2-3-5-9(8)10(11)12-7/h2-6H,1H3 |
| Refractive Index | 1.673 (estimated) |
As an accredited 4-Bromo-2-Methylquinoline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-Bromo-2-Methylquinoline prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
My experience with quinoline derivatives stretches back to years spent researching specialty chemicals for the pharmaceutical and fine chemical sectors. Among these, 4-Bromo-2-Methylquinoline stands out as a molecule that often sparks the interest of chemists and process engineers alike. This compound, categorized by its CAS number 80498-16-0, belongs to a class that has long shown its worth in both medicinal and material science laboratories. A methyl group anchors at position two of the quinoline ring, while a bromine atom claims position four, giving the structure a rich potential for selective reactions and downstream modifications.
In terms of appearance, the substance usually presents as a pale-yellow crystalline powder. Labs keep this material sealed, dry, and away from direct sunlight to protect its stability—a straightforward but critical routine for anyone working with moisture- and air-sensitive intermediates. Through each shipment and batch, the consistency of physical characteristics points toward a high degree of purity—a factor that anyone involved in synthesis or scale-up will appreciate, and one I’ve found makes a difference in reproducibility batch after batch.
Over the years, I’ve watched how synthetic organic chemists lean on this compound when they need to introduce methyl and bromo functionalities at precise points on a quinoline backbone. The quinoline skeleton already has strong significance, acting as a backbone in medicinal chemistry, thanks to how it mimics and improves on naturally occurring alkaloids. Adding bromine and methyl substituents opens new doors—especially for those aiming to construct complex molecular targets such as antimalarial agents, kinase inhibitors, or new fluorophores.
Many new drug candidates that emerged during the last decade incorporated quinoline motifs in their structure, a trend supported by several publications in peer-reviewed journals. 4-Bromo-2-Methylquinoline fits in as a reliable intermediate that makes those syntheses possible. The position of the bromine, in particular, offers versatile reactivity. Through palladium-catalyzed coupling reactions—Suzuki, Sonogashira, or Buchwald-Hartwig, to name a few—the bromo group can be swapped out or extended, often without unwanted side reactions. Anyone who has lost time and resources due to poor selectivity during scale-up will value having a reagent like this one, proven to deliver cleaner transformations with less troubleshooting.
Beyond pharmaceuticals, ligands and OLEDs give further context for its relevance. Material scientists rely on substituted quinolines for new optoelectronic materials and catalysts. Finding a reliably pure precursor helps to ensure the final device properties stay on target—a lesson I learned firsthand after seeing how minute impurities in early material batches led to inconsistent electrical performance.
Conversations with colleagues across different labs always seem to circle back to one point: chemical supply is about more than just a label. 4-Bromo-2-Methylquinoline, in its most trusted form, is available as a refined crystalline solid, generally stored in containers of 1 gram to multi-kilogram lots, depending on research or production scale. Experienced chemists recognize the scent—sweet, faintly aromatic, cut by the sharp note of the bromine atom. Melting points reported from multiple sources range around 70–74°C, and thin-layer chromatography usually delivers a single spot, a sign of purity above 98%. Such details matter, especially when scaling from bench to pilot plant, and the consistency supports reliable downstream reactions.
Solubility proves another practical concern. Most organic solvents—dichloromethane, chloroform, and even hot ethyl acetate—handle the material well. Water solubility remains negligible, reducing risks of hydrolysis during sensitive steps. In personal experience, this solubility profile streamlines workups and purifications, and maintains product integrity through challenging reaction conditions. NMR and HPLC are two common tools for batch verification, and the crisp spectrum signals a high-quality lot; I’ve seen how even subtle missteps in purification can lead to unexpected signals and wasted time, so this routine quality assurance step builds trust.
Every synthetic chemist faces a sea of choices. The subtle difference between a 4-bromo and a 3-bromo (or even a 4-chloro) group on the quinoline core sets a direction for the synthetic route. Compared with common derivatives like 2-methylquinoline or 4-chloro-2-methylquinoline, the 4-bromo variant brings a distinct reactivity pattern. Its bromine, sitting at the para position, undergoes cross-coupling with a broader variety of substrates at milder conditions, making it a favorite for constructing more elaborate molecules with less harsh reagents and lower risk of side-product formation.
From personal experience, especially during a multi-step synthesis for a kinase inhibitor candidate, replacing a 4-chloro with a 4-bromo compound shaved days off the timeline and required less heat and base load—a real-world gain that matters for both the bottom line and safety in the lab. These differences carry through into product stability during storage and handling; bromo derivatives often demonstrate a longer shelf-life under inert gas without the need for refrigeration or specialty stabilizers.
Certain substitution patterns interfere with later-stage transformations, and the combination of methyl at the two position and bromo at four provides a unique balance. The methyl group increases electron density around the quinoline ring, shifting reactivity toward more predictable outcomes in electrophilic and nucleophilic substitution, while the bromo group offers a handle for cross-coupling without the steric hindrance or sluggish reactions seen with ortho-substituted analogues. Comparative studies, including internal R&D projects I’ve worked on, showed increased yield consistency using this scaffold—often between five and fifteen percent more compared to alternative halogenated quinoline derivatives.
The greatest value of 4-Bromo-2-Methylquinoline reveals itself in practice. Early on, I learned that time spent choosing building blocks wisely always pays off down the line. This compound’s place in medicinal chemistry is well supported, thanks to its enabling role for heterocyclic diversification. Researchers targeting antimalarial and antibacterial quinolines depend on the easy modification pathway the bromo group enables. Peptide and small molecule libraries, in particular, benefit from high conversion rates and minimal byproduct generation.
On the manufacturing floor, cost-per-gram calculations put derivatives like this one near the sweet spot: premium enough to justify high-purity standards, economical enough to use at pilot and process development scale. In preparation for a clinical batch of a novel oncology drug, switching to high-purity 4-Bromo-2-Methylquinoline in the assembly line allowed a smoother transition between kilogram and multi-kilogram quantities, saving hours for quality control and minimizing the risk of failed batches.
In electronic materials, the structural backbone lends itself to the synthesis of ligands, chelating agents, and material precursors used in organic light-emitting diodes (OLEDs). Customers aiming for high-performance OLED components often specify this compound due to the clean conversion in downstream reactions. I’ve seen academic labs and commercial partners alike value the simplicity it brings to scale-up and the clarity of NMR and MS spectra they receive at each step.
Seasoned scientists know that lot-to-lot consistency stands at the core of successful synthesis. Many suppliers tout purity figures, but a discerning chemist looks deeper: clean melting points, sharp HPLC chromatograms, and no sign of residual starting materials. Through years in R&D, I saw how small traces of unwanted halides or unreacted starting quinoline create headaches for downstream chemistry. With high-purity 4-Bromo-2-Methylquinoline, those setbacks shrink. Clean reagents mean shorter purification steps, lower waste, and faster timelines—the kinds of benefits that turn competitive projects into true commercial winners.
Batch certification practices, like third-party lab validation and robust in-house NMR, support confidence for those pushing new ideas or scaling up key intermediates. Modern labs expect nothing less than transparent sourcing, traceable lot numbers, and COAs reflecting more than just purity—a reflection of the growing demand for trust and transparency, particularly among those managing regulated drug development pipelines. Consistent documentation and a clear record of analytical performance turn a vendor from a supplier into a partner.
Every chemist walks a line between maximizing reagent health and keeping lab risks in check. Having worked with moisture- and air-sensitive aromatics for years, I learned simple routines keep 4-Bromo-2-Methylquinoline at its best. Airtight containers, cool rooms out of sunlight, and inert gas overlays do most of the heavy lifting. Some labs go further with vacuum desiccation or glovebox storage, but for most scales, careful basic protocols pay off handsomely.
During summer stretches or high-humidity winters, those protocols block the slow drift in melting point or color that signals decomposing stock. I’ve seen the impact of letting down the guard—even a day uncovered invites hydrolysis and a frustrating loss of quality. Small steps like labeling dates on fresh jars and logging inventory make a practical difference, especially across large teams with rotating members. Instituting daily checks on reagent stocks, lot records, and reaction logs reinforces those habits.
No intermediate, no matter how well-made, escapes the practical challenges of modern chemistry. Sourcing reliability stays at the top of the list. Disruptions from regulatory shifts or supply chain hiccups can echo through a project timeline. Over the last few years, new sourcing partners and contingency planning became standard practice, both for commercial processors and research groups. Working directly with suppliers for assurance on production scale and ongoing inventory proves worthwhile, particularly for teams setting ambitious project deadlines.
Waste disposal also brings concerns, especially as green chemistry initiatives move from policy talk to active practice. Brominated aromatics require care in handling spent reagents and mother liquors. On several projects, working closely with the environmental health and safety (EHS) team to refine protocols paid off. Choosing extra clean starting materials, such as high-grade 4-Bromo-2-Methylquinoline, ultimately leads to less off-spec byproduct and a more efficient recycling stream. Researchers pushing the bounds of cross-coupling technologies often weigh the reagent’s cost in both dollar and environmental terms, leaning toward those that promise the cleanest transformation profiles.
Transitioning from pilot to production scale sometimes exposes kinetic quirks or solubility challenges that lab-scale reactions don’t reveal. Collaborating with process engineers, I found that consistent, data-driven process validation helped smooth those bumps, catching issues before they snowball. Reliable analytical support, routine batch audits, and feedback loops between synthesis and processing teams help keep projects on track.
The last few years brought increased attention to late-stage functionalization, modular molecular assembly, and sustainable catalytic methods. Here, 4-Bromo-2-Methylquinoline holds steady as a reliable, easily modified intermediate. As new palladium and nickel-catalyzed techniques emerge, the role of finely tuned bromoquinoline derivatives only grows. I’ve seen start-ups and academic center collaborations pursue entirely new targets, aiming for drug molecules with enhanced selectivity or material components with improved photostability, all springing from this sturdy starting point.
Workflows that once relied on more basic halides now gravitate toward the clean conversions and controlled selectivity offered by the bromo-methyl pairing of this compound. As regulatory expectations grow more sophisticated, and green chemistry practices inch forward, having an intermediate that reliably performs and minimizes waste becomes more of a necessity than an option. In my time bridging R&D and manufacturing, those shifts shaped project choices and long-term supplier relationships.
Industry and academic demands rarely move at the same pace, but shared needs bring them together over intermediates like 4-Bromo-2-Methylquinoline. Cutting-edge drug discovery, advanced material science, and process development rely on these specialty building blocks. Among the new crop of organic intermediates, this particular quinoline derivative continues to hold favor for one simple reason: it works. Clean structure, reliable performance, and robust supply support time-sensitive work across different disciplines.
The push for safer, greener, and more transparent chemical supply only raises the bar for intermediates. Researchers want more than a commodity—they demand a reagent they can depend on, one able to bear the weight of complex synthetic plans and tight production schedules. From years spent across academic labs and industrial pipelines, I saw how strong partnerships with suppliers, open lines of communication about analytical data, and a willingness to troubleshoot improve every step of the value chain. Solutions to persistent challenges in chemical supply and waste come not just from the compounds themselves, but from the community’s evolving expectations for performance and responsibility.
The story of 4-Bromo-2-Methylquinoline isn’t one of headline-grabbing innovation, but of steady, meaningful contribution. For years, this compound has delivered value by doing its job well—serving as a versatile and reliable building block for new molecules and new ideas. Its unique substitution pattern, strong performance in coupling reactions, and consistent purity make it a staple for professionals who refuse to cut corners.
As demands for transparency, sustainability, and quality accelerate, there’s more reason than ever to place trust in intermediates with a proven record. The spectrum of applications—across drugs, materials, and complex organic synthesis—only underlines the role of this compound in supporting modern scientific progress. Relying on the lessons of experience and the evidence of careful experimentation, 4-Bromo-2-Methylquinoline holds its place as a foundation for new discoveries and enduring professional trust.